NEIL3 promotes the carcinogenesis of prostate cancer by activating PI3K/Akt/mTOR signaling
Abstract Prostate cancer (PCa) is one of the most common cancers worldwide. Nei endonuclease VIII-like 3 (NEIL3) plays important roles in diverse cancers. In this study, we found that NEIL3 was overexpressed in PCa tissues and cell lines. NEIL3 over-expression was associated with worse prognostic ou...
Saved in:
| Main Authors: | Wei Zhang, Zihao Liu, Simeng Wen, Yuan Shao, Zhen Yang, Yong Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02625-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessments of prostate cancer cell functions highlight differences between a pan‐PI3K/mTOR inhibitor, gedatolisib, and single‐node inhibitors of the PI3K/AKT/mTOR pathway
by: Adrish Sen, et al.
Published: (2025-01-01) -
Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway
by: Rongwang Guo, et al.
Published: (2025-03-01) -
Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
by: Young-Jin Choi, et al.
Published: (2024-05-01) -
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
Platycodin D induces apoptosis in human prostate carcinoma cells via ROS-dependent inactivation of the PI3K/AKT/mTOR signaling pathway
by: Yung Hyun Choi
Published: (2025-05-01)